Pesquisar
Phibro Animal Health Corp
PAHCAdicionar à lista de desejos
34.370USD
-1.780-4.92%
Fechamento 05/15, 16:00（ET）Cotações atrasadas em 15 min
1.39BValor de mercado
14.63P/L TTM
Mais detalhes de Phibro Animal Health Corp Empresa
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Informações de Phibro Animal Health Corp
Código da empresaPAHC
Nome da EmpresaPhibro Animal Health Corp
Data de listagemApr 11, 2014
CEOBendheim (Jack C)
Número de funcionários2475
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 11
EndereçoGlenpointe Centre East, 3Rd Floor
CidadeTEANECK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07666
Telefone12013297300
Sitehttps://www.pahc.com/
Código da empresaPAHC
Data de listagemApr 11, 2014
CEOBendheim (Jack C)
Executivos da empresa Phibro Animal Health Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+3.98%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+3.98%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
MFAs and Other
202.11M
54.05%
Nutritional specialties
50.23M
13.43%
Vaccines
37.64M
10.07%
Por RegiãoUSD
Nome
Receita
Proporção
United States
221.76M
59.31%
Latin America and Canada
87.60M
23.43%
Europe & Middle East & Africa
44.78M
11.98%
Asia Pacific
19.77M
5.29%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
MFAs and Other
202.11M
54.05%
Nutritional specialties
50.23M
13.43%
Vaccines
37.64M
10.07%
Distribuição de ações
Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.89%
State Street Investment Management (US)
4.47%
Vanguard Capital Management, LLC
4.23%
Millennium Management LLC
3.04%
Acadian Asset Management LLC
2.93%
Outro
71.44%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.89%
State Street Investment Management (US)
4.47%
Vanguard Capital Management, LLC
4.23%
Millennium Management LLC
3.04%
Acadian Asset Management LLC
2.93%
Outro
71.44%
Tipos de investidores
Investidores
Proporção
Investment Advisor
53.06%
Investment Advisor/Hedge Fund
28.56%
Hedge Fund
10.67%
Research Firm
2.76%
Pension Fund
1.42%
Bank and Trust
0.69%
Individual Investor
0.59%
Corporation
0.46%
Family Office
0.39%
Outro
1.42%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
474
22.03M
104.57%
-645.50K
2025Q4
432
20.14M
97.68%
-3.60M
2025Q3
390
21.83M
106.75%
-2.29M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
2.93M
14.19%
+6.03K
+0.21%
Dec 31, 2025
State Street Investment Management (US)
942.28K
4.57%
+48.24K
+5.40%
Dec 31, 2025
Millennium Management LLC
641.31K
3.11%
+626.49K
+4227.06%
Dec 31, 2025
Acadian Asset Management LLC
702.65K
3.41%
-83.17K
-10.58%
Dec 31, 2025
Geode Capital Management, L.L.C.
569.11K
2.76%
+21.95K
+4.01%
Dec 31, 2025
Renaissance Technologies LLC
545.30K
2.64%
-9.90K
-1.78%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
492.33K
2.39%
+6.83K
+1.41%
Dec 31, 2025
Fidelity Management & Research Company LLC
477.06K
2.31%
+63.44K
+15.34%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
AAM Sawgrass US Small Cap Quality Growth ETF
2.49%
State Street SPDR S&P Pharmaceuticals ETF
1.19%
Innovator IBD 50 Fund ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
1.06%
Inspire Fidelis Multi Factor ETF
1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.02%
Lattice Hartford Multifactor Small Cap ETF
0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco NASDAQ Future Gen 200 ETF
0.61%
Invesco S&P SmallCap Health Care ETF
0.52%
Ver Mais
AAM Sawgrass US Small Cap Quality Growth ETF
Proporção2.49%
State Street SPDR S&P Pharmaceuticals ETF
Proporção1.19%
Innovator IBD 50 Fund ETF
Proporção1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporção1.06%
Inspire Fidelis Multi Factor ETF
Proporção1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporção1.02%
Lattice Hartford Multifactor Small Cap ETF
Proporção0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção0.76%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.61%
Invesco S&P SmallCap Health Care ETF
Proporção0.52%
Dividendo
Um total de
97.20M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
May 05, 2026
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Jun 24, 2026 going ex on Jun 03, 2026
Jun 03, 2026
Jun 24, 2026
Jun 03, 2026
Feb 03, 2026
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 25, 2026 going ex on Mar 04, 2026
Mar 04, 2026
Mar 25, 2026
Mar 04, 2026
Nov 04, 2025
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 17, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 17, 2025
Nov 26, 2025
Jul 29, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 24, 2025 going ex on Sep 03, 2025
Sep 03, 2025
Sep 24, 2025
Sep 03, 2025
May 06, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 25, 2025 going ex on Jun 04, 2025
Jun 04, 2025
Jun 25, 2025
Jun 04, 2025
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Ver Mais
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
